Lifeway Foods Files 8-K on Financials
Ticker: LWAY · Form: 8-K · Filed: Jan 6, 2025 · CIK: 814586
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: LWAY
TL;DR
Lifeway Foods dropped an 8-K on Jan 6th detailing financials. Check it out.
AI Summary
Lifeway Foods, Inc. filed an 8-K on January 6, 2025, reporting on its results of operations and financial condition. The filing also included Regulation FD disclosures and financial statements and exhibits. The company is incorporated in Illinois and its principal executive offices are located at 6431 Oakton Street, Morton Grove, Illinois.
Why It Matters
This 8-K filing provides investors with crucial updates on Lifeway Foods' financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any unusual or significant risks.
Key Players & Entities
- Lifeway Foods, Inc. (company) — Registrant
- January 6, 2025 (date) — Date of earliest event reported
- Illinois (location) — State of incorporation
- 6431 Oakton Street, Morton Grove, Illinois 60053 (address) — Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K filing?
The filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details are not provided in the header.
When was the earliest event reported in this filing?
The earliest event reported is January 6, 2025.
What is the principal executive office address for Lifeway Foods, Inc.?
The principal executive offices are located at 6431 Oakton Street, Morton Grove, Illinois 60053.
In which state is Lifeway Foods, Inc. incorporated?
Lifeway Foods, Inc. is incorporated in Illinois.
What is the Commission File Number for Lifeway Foods, Inc.?
The Commission File Number for Lifeway Foods, Inc. is 001-42398.
Filing Stats: 1,174 words · 5 min read · ~4 pages · Grade level 12.4 · Accepted 2025-01-06 08:25:20
Key Financial Figures
- $45.1 million — s that (a) net sales will range between $45.1 million and $46.6 million for the three-month p
- $46.6 million — es will range between $45.1 million and $46.6 million for the three-month period ended Decemb
- $42.1 million — period ended December 31, 2024, up from $42.1 million for the same three-month period in 2023
- $185.0 million — -year 2024 net sales will range between $185.0 million and $186.5 million, up from $160.1 mill
- $186.5 m — s will range between $185.0 million and $186.5 million, up from $160.1 million in 2023."
- $160.1 million — 5.0 million and $186.5 million, up from $160.1 million in 2023." Item 7.01. Regulation FD Dis
Filing Documents
- lway-8k_010625.htm (8-K) — 34KB
- ex99-1.htm (EX-99.1) — 48KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- 0001999371-25-000134.txt ( ) — 318KB
- lway-20250106.xsd (EX-101.SCH) — 4KB
- lway-20250106_def.xml (EX-101.DEF) — 29KB
- lway-20250106_lab.xml (EX-101.LAB) — 36KB
- lway-20250106_pre.xml (EX-101.PRE) — 26KB
- lway-8k_010625_htm.xml (XML) — 5KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On January 6, 2025, on behalf of the board of directors (the " Board ") of Lifeway Foods, Inc., an Illinois corporation (the " Company "), counsel to the Company sent a letter (the " Response Letter ") to Danone North America PBC (" Danone "), responding to the letter that Danone sent to the Company on December 30, 2024. The Response Letter states that, "Based on current preliminary and unaudited projections, the Company expects that (a) net sales will range between $45.1 million and $46.6 million for the three-month period ended December 31, 2024, up from $42.1 million for the same three-month period in 2023, and (b) full-year 2024 net sales will range between $185.0 million and $186.5 million, up from $160.1 million in 2023."
01. Regulation
Item 7.01. Regulation FD Disclosure. On January 6, 2025, on behalf of the Board, counsel to the Company sent the Response Letter to Danone. The Response Letter is furnished as Exhibit 99.1 to this Current Report and is incorporated herein by reference. This Current Report and Exhibit 99.1 hereto contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include all statements that are not historical statements of fact and those regarding the Company's intent, belief, plans or expectations for the Company's business, operations, financial performance or condition, including, without limitation, statements regarding expected net sales and Adjusted EBITDA. These statements use words such as "continue," "believe," "expect," "anticipate," "plan," "project," "estimate," "outlook," "potential," "forecast" and similar expressions or future or conditional verbs such as "will," "should," "would," "may" and "could." You are cautioned not to rely on these forward-looking statements. These forward-looking statements are made as of the date of this Current Report, are based on current expectations of future events and thus are inherently subject to a number of risks and uncertainties, many of which involve factors or circumstances beyond the Company's control. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the Company's expectations and projections. These risks, uncertainties and other factors include: price competition; the decisions of customers or consumers; the actions of competitors; changes in the pricing of commodities; the effects of government regulation; possible delays in the introduction of new products; customer acceptance of products and services; and other factors discussed in Part I, Item 1A "Risk Factors" of the Company'
01. Financial
Item 9.01. Financial (d) Exhibits: Exhibit No. Description 99.1 Letter, dated January 6, 2025, from Company Counsel to Danone North America PBC 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LIFEWAY FOODS, INC. Date: January 6, 2025 By: /s/ Julie Smolyansky Name: Julie Smolyansky Title: Chief Executive Officer and Secretary